Gracell Biotechnologies Inc.: eps_basic
| Value | {"per": "shares", "amount": 0.9, "concept": "us-gaap:EarningsPerShareBasic", "currency": "CNY"} |
|---|---|
| Period | 2022-01-01 – 2022-06-30 |
| Status | superseded |
| Entity | Gracell Biotechnologies Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/13067f59-f7c5-4d44-81ea-181b73b3fd6d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-221202Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001826492/eps-basic/2022-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/13067f59-f7c5-4d44-81ea-181b73b3fd6d
History
- no predecessors — first report